Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets EXMKT - Delayed Quote USD

Positive Physicians Holdings, Inc. (PPHI)

Compare
6.90
0.00
(0.00%)
At close: March 31 at 4:00:00 PM EDT
Loading Chart for PPHI
  • Previous Close 6.95
  • Open 6.95
  • Bid --
  • Ask --
  • Day's Range 6.90 - 6.95
  • 52 Week Range 6.50 - 8.00
  • Volume 2,150
  • Avg. Volume 0
  • Market Cap (intraday) 24.947M
  • Beta (5Y Monthly) 0.07
  • PE Ratio (TTM) --
  • EPS (TTM) -0.60
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Feb 2, 2024
  • 1y Target Est --

Positive Physicians Holdings, Inc., through its subsidiary Positive Physicians Insurance Company, provides medical malpractice insurance. The company underwrites claims-made, claims-made plus, tail, and occurrence-based medical professional liability coverage for physicians, corporations, medical groups, clinics, and allied healthcare providers. It sells its medical professional liability insurance products through approximately 82 retail producers in the territories of Pennsylvania, New Jersey, Ohio, Delaware, Maryland, South Carolina, Michigan, Florida, and Texas. The company was founded in 2002 and is based in Berwyn, Pennsylvania. Positive Physicians Holdings, Inc. operates as a subsidiary of Insurance Capital Group, LLC.

www.positivephysicians.com

23

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PPHI

View More

Performance Overview: PPHI

Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PPHI
0.00%
S&P 500 (^GSPC)
4.23%

1-Year Return

PPHI
6.15%
S&P 500 (^GSPC)
7.42%

3-Year Return

PPHI
0.21%
S&P 500 (^GSPC)
23.92%

5-Year Return

PPHI
8.60%
S&P 500 (^GSPC)
128.01%

Compare To: PPHI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PPHI

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.28%

  • Return on Assets (ttm)

    -1.25%

  • Return on Equity (ttm)

    -3.51%

  • Revenue (ttm)

    22.34M

  • Net Income Avi to Common (ttm)

    -2.52M

  • Diluted EPS (ttm)

    -0.60

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.2M

  • Total Debt/Equity (mrq)

    4.87%

  • Levered Free Cash Flow (ttm)

    7.02M

Research Analysis: PPHI

View More

Company Insights: PPHI

Research Reports: PPHI

View More

People Also Watch